Interim safety data from the FORTIS study were presented at WORLDSympsoium.
Abby Reinhard
Advertisement
Articles by Abby Reinhard
The FDA has placed the investigational new drug application for the treatment on clinical hold.
Advertisement
Latest Updated Articles
Gene Therapy Well-Tolerated in Late-Onset Pompe DiseasePublished: February 13th 2022 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
